Dr. Jasbir S. Seehra is a prominent biotechnology executive and scientist who serves as the President, Chief Executive Officer, and Chairman of the Board of Keros Therapeutics. With an extensive professional background spanning decades of leadership roles within the biopharmaceutical industry, he has dedicated his career to advancing protein-engineering platforms and translating complex scientific discoveries into clinical-stage therapies. Under his executive guidance, Keros has progressed from an early-stage research enterprise into a publicly traded clinical-stage company dedicated to developing innovative treatments for rare and severe diseases.